Co-tenidone 100mg/25mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

co-tenidone 100mg/25mg tablets

wockhardt uk ltd - atenolol; chlortalidone - oral tablet - 100mg ; 25mg

Atenolol/Chloortalidone EG 100 mg - 25 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atenolol/chloortalidone eg 100 mg - 25 mg tabl.

eg sa-nv - chlortalidone 25 mg; atenolol 100 mg - tablet - 100 mg - 25 mg - chlortalidone 25 mg; atenolol 100 mg - atenolol and other diuretics

Atenolol/Chloortalidone EG 50 mg - 12.5 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atenolol/chloortalidone eg 50 mg - 12.5 mg tabl.

eg sa-nv - chlortalidone 12,5 mg; atenolol 50 mg - tablet - 50 mg - 12,5 mg - chlortalidone 12.5 mg; atenolol 50 mg - atenolol and other diuretics

Tenoretic Mitis 50/12,5 50 mg - 12.5 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

tenoretic mitis 50/12,5 50 mg - 12.5 mg film-coat. tabl.

atnahs pharma netherlands b.v. - chlortalidone 12,5 mg; atenolol 50 mg - film-coated tablet - 50 mg - 12,5 mg - chlortalidone 12 mg; atenolol 50 mg - atenolol and other diuretics

Hygroton New Zealand - English - Medsafe (Medicines Safety Authority)

hygroton

novartis new zealand ltd - chlortalidone 100mg - tablet - 100 mg - active: chlortalidone 100mg

Hygroton New Zealand - English - Medsafe (Medicines Safety Authority)

hygroton

aft pharmaceuticals ltd - chlortalidone 25mg;   - tablet - 25 mg - active: chlortalidone 25mg   excipient: colloidal silicon dioxide iron oxide red iron oxide yellow lactose monohydrate magnesium stearate maize starch purified talc - arterial hypertension, essential or nephrogenic or isolated systolic, as primary therapy or in combination with other antihypertensive agents. stable, chronic heart failure of mild to moderate degree (new york heart association, nhya: functional class ii or iii). - oedema of specific origin - oedema due to peripheral (chronic) venous insufficiency; short-term therapy if physical measures prove insufficient. - fluid retention in premenstrual syndrome only if the gain in weight is the main symptom and is well documented. - ascites due to cirrhosis of the liver in stable patients under close control. - oedema due to nephrotic syndrome. - prophylaxis against recurrent calcium oxalate calculi in patients with idiopathic, normocalcaemic hypercalciuria.

Hygroton New Zealand - English - Medsafe (Medicines Safety Authority)

hygroton

novartis new zealand ltd - chlortalidone 50mg - tablet - 50 mg - active: chlortalidone 50mg

Hygroton K New Zealand - English - Medsafe (Medicines Safety Authority)

hygroton k

novartis new zealand ltd - chlortalidone 25mg; potassium chloride 500mg - tablet - 25mg/500mg - active: chlortalidone 25mg potassium chloride 500mg

Lopresoretic New Zealand - English - Medsafe (Medicines Safety Authority)

lopresoretic

novartis new zealand ltd - chlortalidone 100mg; metoprolol tartrate 12.5mg - tablet - 12.5mg/100mg - active: chlortalidone 100mg metoprolol tartrate 12.5mg

Regroton New Zealand - English - Medsafe (Medicines Safety Authority)

regroton

sanofi-aventis new zealand limited - chlortalidone 50mg; reserpine 0.25mg - tablet - 50mg/0.25mg - active: chlortalidone 50mg reserpine 0.25mg